Learn More
Invitrogen™ SLAMF9 Polyclonal Antibody

Description
Recommended positive controls: Jurkat, Raji. Predicted reactivity: Human (99%), Rhesus Monkey (92%), Chimpanzee (97%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | SLAMF9 |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 0.85 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 |
| Gene | SLAMF9 |
| Gene Accession No. | Q96A28 |
| Gene Alias | 2310026I04Rik; AI462096; CD2 antigen family, member 10; CD2 family member 10; CD2F10; CD2F-10; CD84 homolog 1; CD84H1; CD84-H1; cluster of differentiation 2 antigen family member 10; cluster of differentiation 84 homolog 1; RP11-48O20.3; SF2001; signaling lymphocytic activation molecule family member 2001; signaling lymphocytic activation molecule family member 9; SLAM family member 9; SLAMF9; UNQ1938/PRO4421 |
| Gene Symbols | SLAMF9 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.